Funded Startups in Geneva
Geneva’s most recent disclosed rounds show one extreme size outlier: Gavi, the Vaccine Alliance’s $1.0B debt financing on 2022-05-16 dwarfs the next-larges…
Geneva’s most recent disclosed rounds show one extreme size outlier: Gavi, the Vaccine Alliance’s $1.0B debt financing on 2022-05-16 dwarfs the next-largest disclosed amount in these rows ($490K, held by Backbone on 2026-06-22 and also by Transform Health on 2023-12-20; with the next-largest disclosed after that at $233M for BGN on 2025-02-19). Amounts also cluster temporally: four rounds in early/mid June 2026 (Backbone 2026-06-22 $490K; Cria Technologies 2026-06-21 $120K; ZAAN 2026-06-16 $5M; Combioxin S.A. 2026-06-10 $1M) and another concentration around 2025-02 (Sparta 2025-02-24 $42M; BGN 2025-02-19 $233M). Despite the “Geneva” listing, geography is mostly Geneva proper but includes two “Geneva, New York, United States” entries (Cheribundi on 2022-04-20 undisclosed; RealEats on 2021-10-26 $16M), and one “Geneva, United States” row (VM Agritech on 2025-11-28 $18M). Stage and disclosure are mixed: Series Unknown appears 26 times, and undisclosed amounts appear 10 times across 50 rows, with biotechnology showing up in at least 6 entries (e.g., Neurosoft Bioelectronics $8M on 2026-05-20; GeNeuro $5M on 2024-02-01; GliaPharm undisclosed on 2024-09-17). The visible window spans 2021-10-26 (RealEats) through 2026-06-22 (Backbone).
Most recent rounds
50 of 533 more funded startups
This page shows the 50 most recent rounds (back to Oct 2021). The full 53-company history for this listing is available on a paid plan.
Unlock all 53 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What stands out as an outlier by disclosed amount in these Geneva rounds, and what’s the size gap to the rest?
Gavi, the Vaccine Alliance’s $1.0B debt financing on 2022-05-16 is far above the rest of the disclosed amounts shown; the next-largest disclosed amount is $490K (Backbone on 2026-06-22 and Transform Health on 2023-12-20), with BGN at $233M on 2025-02-19 still well below the outlier.
Do the most recent rounds cluster in a specific time window rather than being evenly spread?
Yes. Four entries land within roughly two weeks in June 2026: Backbone ($490K) on 2026-06-22, Cria Technologies ($120K) on 2026-06-21, ZAAN ($5M) on 2026-06-16, and Combioxin S.A. ($1M) on 2026-06-10.
Is the location consistently “Geneva, Switzerland,” or do similarly named cities show up in the table?
Most rows are “Geneva, Geneve, Switzerland,” but there are geographic deviations: Cheribundi is listed as “Geneva, New York, United States” on 2022-04-20 (undisclosed), RealEats is “Geneva, New York, United States” on 2021-10-26 ($16M), and VM Agritech is “Geneva, United States” on 2025-11-28 ($18M).
How much of the dataset is hard to size by stage or amount (e.g., Series Unknown or undisclosed)?
The listing is heavily classification- or disclosure-limited: “Series Unknown” appears 26 times, and “undisclosed” amounts appear 10 times. Examples include Tech5.ai (Series Unknown, undisclosed) on 2026-01-21 and Clee Medical (Seed, undisclosed) on 2026-02-25.
Are any sectors over-represented relative to the rest of the table?
Biotechnology is the clearest dense cluster, appearing in at least 6 entries: Neurosoft Bioelectronics ($8M) on 2026-05-20, Cria Technologies ($120K) on 2026-06-21, Combioxin S.A. ($1M) on 2026-06-10, GeNeuro ($5M) on 2024-02-01, and GliaPharm (undisclosed) on 2024-09-17 among others.
Which stage labels recur around larger rounds versus smaller or undisclosed ones?
Large disclosed rounds concentrate in specific stage labels: BGN’s $233M is “Series Unknown” on 2025-02-19, Sparta’s $42M is “Series B” on 2025-02-24, and Planetary’s $21M is “Series A” on 2026-04-20. By contrast, several smaller entries with “Series Unknown” include Backbone ($490K) on 2026-06-22 and UNBOOUND ($130K) on 2026-04-22, while undisclosed amounts appear across multiple stage labels (e.g., Haisai on 2023-06-05, undisclosed).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.